Critical appraisal is the ability to judge the
persuasiveness of the evidence in a research study.
You have to strike the proper balance between being too
harsh and being too accepting of research findings.
Articles are arranged by date with the most recent entries at the top. You can find outside resources at the bottom of this page.
Other entries about critical appraisal can be found in the
critical appraisal page at the
StATS website.
2010
-
P.Mean: Is Evidence-Based Medicine too rigid
(created 2010-08-19). Someone was asking about criticisms of Evidence-Based
Medicine (EBM) that the reliance on grading schemes and the hierarchy of
evidence was too rigid or was EBM providing some heuristics that could be
adapted as needed. This is hard to respond to, but it is an important question.
I view checklists and hierarchies as a necessary evil, and that sometimes they
are applied too rigidly.
-
P.Mean: Is intuition real? (created 2010-02-25).
Someone asked if intuition is real. My hunch is that intuition is may be real,
but it is grossly overrated.
-
P.Mean: Humility is a good thing for
researchers to have (created 2010-02-08). I've been writing a series of
articles about the seven deadly sins of researchers. One of these sins is
pride. I might need to talk about the alternative to pride, which is humility.
I believe that researchers should adopt a humble outlook. Humility is often
misunderstood as a bad thing. It is not.
2009
-
P.Mean: Integrating internal and
external evidence (created 2006-03-17). This article was originally
published on my old website, but it seems to have disappeared. I'm reproducing
it here with a few revisions. Evidence based medicine involves the combining of
the best available evidence with your clinical knowledge and the patient's
individual values. A good article that emphasizes how this should be done is on
the web at: Evidence-based decision making--the six step approach. Franz
Porzsolt, Andrea Ohletz, Anke Thim, David Gardner, Helmuth Ruatti, Horand
Meier, Nicole Schlotz-Gorton, Laura Schrott. Evid Based Med 2003: 8(6);
165-166.
2008
-
P.Mean: Reading abstracts instead of the
full article (created 2008-11-05). An interesting inquiry on the
Evidence-Based Health email discussion group generated a lot of responses. A
busy clinician has a limited amount of time to answer a clinical question. They
carry out a quick search and find 5 decent abstracts. They have two options: 1)
Look at one full-text article. 2) Look at 5 abstracts. Which do people think is
preferable? It's a tricky question because both approaches have problems.
Here are my thoughts on this issue.
-
P.Mean: Errors in statistical
methodology (created 2008-10-19). From those of you who review/appraise
articles regularly, I would like to hear what kinds or errors you find most
often in the statistical methodology. I will be training nurses to critically
appraise the statistical methodology sections of articles, and since their time
and knowledge of statistics are limited, I hope to focus mainly on errors they
are likely to find in real articles.
-
P.Mean: Godwin's Law (created 2008-10-05).
There is a tendency in some discussions (mostly with a political focus, but
also in some with a medical focus), to invoke the name of Adolph Hitler in
criticizing one's opponents or to compare one's opponents to Nazis. This is
sometimes called the Reductio ad Hitlerum fallacy or the Argumentum ad Nazium
fallacy.
-
P.Mean: The depths of
anti-intellectualism (created 2008-09-05). My brother-in-law is an avid
conservative and often sends me political commentary that would make Attila the
Hun blush. That's actually a good thing, as it makes me think things through
more carefully. He recently made a sarcastic comment about the lack of
experience of Barack Obama ("the guy with the resume consisting of two good
speeches"). It made me think a bit more about a topic of general interest to me
and one that goes well beyond politics: the rise of anti-intellectualism in the
United States. Here's what I wrote back to him in response.
-
P.Mean: Where to look for information in
a controversial area (created 2008-08-20). I am currently researching
vaccinations and the negative effects they may cause. My ex-boyfriend is
against vaccines and I am for them. I was wondering if you could give me some
references to research supporting the autism link not being caused by vaccines
or actually any other theory regarding vaccines being harmful to the body. I
went to a seminar and they told us there is a problem with molecular mimicry
where the body may attack itself looking for a sequence similar to the disease.
Any help you can offer would be greatly appreciated. Desperately seeking the
truth.
-
P.Mean: Is there a scientific basis for
EBM? (created 2008-08-20). A pair of articles in Chest, along with two
rebuttals examines two sides to the debate over the validity of Evidence-Based
Medicine (EBM). Point: evidence-based medicine has a sound scientific base: P.
J. Karanicolas, R. Kunz, G. H. Guyatt. Chest 2008: 133(5); 1067-71, and
Counterpoint: evidence-based medicine lacks a sound scientific base. M. J.
Tobin. Chest 2008: 133(5); 1071-4; discussion 1074-7.
-
P.Mean: Quote on anti-intellectualism
(created 2008-08-08). I want to write an article about the growing mistrust
of experts in our society. A working title is "The Rising Tide of
Anti-Intellectualism." Here's a quote that might be worth starting out with.
Outside resources:
-
AGREE (Appraisal of Guidelines REsearch Evaluation) Collaboration.
AGREE Collaboration. Excerpt: AGREE is an international
collaboration of researchers and policy makers who seek to improve the quality
and effectiveness of clinical practice guidelines by establishing a shared
framework for their development, reporting and assessment. This website
was last verified on 2008-URL: www.agreecollaboration.org
- Alternative medicine--the risks of untested and
unregulated remedies. M. Angell, J. P. Kassirer. New England Journal of
Medicine 1998: 339(12); 839-41.
Excerpt: It is time for the scientific community to stop giving alternative
medicine a free ride. There cannot be two kinds of medicine - conventional and
alternative. There is only medicine that has been adequately tested and
medicine that has not, medicine that works and medicine that may or may not
work. Once a treatment has been tested rigorously, it no longer matters
whether it was considered alternative at the outset. If it is found to be
reasonably safe and effective, it will be accepted. But assertions,
speculation, and testimonials do not substitute for evidence. Alternative
treatments should be subjected to scientific testing no less rigorous than
that required for conventional treatments.
- Article makes simple errors and could cause
unnecessary deaths. C. Baigent, R. Collins, R. Peto. British Medical
Journal 2002: 324(7330); 167.
[Medline] [Full
text] [PDF]. Description: This article offers a critical review
of a critical review (Cleland 2002). Cleland cited issues a large randomized
trial of aspirin for prevention of heart attacks and with a meta-analysis.
Baigent et al argue that the claims of Cleland are "wrong for trivial reasons
and potentially damaging to patients."
- Biases in the interpretation and use of research
results. RJ MacCoun. Annu Rev Psychol 1998: 49; 259-87.
[Full text]
[PDF]. Description: This article provides several
fascinating examples of people's tendency to be hypercritical of research
findings that they dislike and to overlook the flaws of research that they
favor.
- Doug Smith. But who's counting? The million-billion mistake is among
the most common in journalism. But why? Excerpt: "The difference
between a million and a billion is a number so vast that it would seem nearly
impossible to confuse the two. Take pennies. At the website of the Mega Penny
Project, you can see that a million pennies stack up to be about the size of a
filing cabinet. A billion would be about the size of five school buses. Or
take real estate. A home in a nice part of Los Angeles might cost a million
dollars. A billion dollars would buy the whole neighborhood. But journalists
can't seem to keep the two numbers straight. Committed as we are to getting
the smallest details right, we seem hopelessly prone to writing "million"
when, in fact, we mean "billion."" [Accessed February 4, 2010]. Available
at:
http://www.latimes.com/news/opinion/commentary/la-oe-smith31-2010jan31,0,2185811.story.
-
Calling all
charlatans. A group of researchers puts companies making scientific claims on
the spot. (Andrea Gawrylewski). Description:
A short article discussing a group of scientists who examine scientific claims
made in advertisements for various products. This website was last
verified on 2007-10-12. URL: www.the-scientist.com/news/home/53699/
- Cochrane Collaboration. The Cochrane Collaboration estimates that only
"10% to 35% of medical care is based on RCTs". On what information is this
estimate based? Excerpt: "The Cochrane Collaboration has not actually
conducted research to determine this estimate; it is possible that the
estimate of 10-35% comes from the following passage in a chapter by Kerr L
White entitled 'Archie Cochrane's legacy: an American perspective' in the book
'Non-random Reflections on Health Services Research: on the 25th anniversary
of Archie Cochrane's Effectiveness and Efficiency'. This book (published by
the BMJ Publishing Group) was edited by Alan Maynard and Iain Chalmers. Iain
was formerly Director of the UK Cochrane Centre, and the driving force behind
the establishment of The Cochrane Collaboration; he knew Archie Cochrane
well." [Accessed February 4, 2010]. Available at:
http://www.cochrane.org/docs/faq.htm#q20.
- John P. A. Ioannidis. Contradicted and Initially Stronger Effects in
Highly Cited Clinical Research. JAMA. 2005;294(2):218-228. Abstract:
"Context: Controversy and uncertainty ensue when the results of clinical
research on the effectiveness of interventions are subsequently contradicted.
Controversies are most prominent when high-impact research is involved.
Objectives: To understand how frequently highly cited studies are contradicted
or find effects that are stronger than in other similar studies and to discern
whether specific characteristics are associated with such refutation over
time. Design: All original clinical research studies published in 3 major
general clinical journals or high-impact-factor specialty journals in
1990-2003 and cited more than 1000 times in the literature were examined. Main
Outcome Measure: The results of highly cited articles were compared against
subsequent studies of comparable or larger sample size and similar or better
controlled designs. The same analysis was also performed comparatively for
matched studies that were not so highly cited. Results: Of 49 highly cited
original clinical research studies, 45 claimed that the intervention was
effective. Of these, 7 (16%) were contradicted by subsequent studies, 7 others
(16%) had found effects that were stronger than those of subsequent studies,
20 (44%) were replicated, and 11 (24%) remained largely unchallenged. Five of
6 highly-cited nonrandomized studies had been contradicted or had found
stronger effects vs 9 of 39 randomized controlled trials (P = .008). Among
randomized trials, studies with contradicted or stronger effects were smaller
(P = .009) than replicated or unchallenged studies although there was no
statistically significant difference in their early or overall citation
impact. Matched control studies did not have a significantly different share
of refuted results than highly cited studies, but they included more studies
with "negative" results. Conclusions: Contradiction and initially stronger
effects are not unusual in highly cited research of clinical interventions and
their outcomes. The extent to which high citations may provoke contradictions
and vice versa needs more study. Controversies are most common with highly
cited nonrandomized studies, but even the most highly cited randomized trials
may be challenged and refuted over time, especially small ones." [Accessed
February 4, 2010]. Available at:
http://jama.ama-assn.org/cgi/content/abstract/294/2/218.
- Development of evidence-based clinical practice guidelines (CPGs):
comparing approaches. Tari Turner, Marie Misso, Claire Harris, and Sally
Green. Implementation Science 2008, 3:45doi:10.1186/1748-5908-3-45.
[Abstract]
[PDF] Description: This article identified publications on developing
clinical practice guidelines. The review found six relevant publications. All
these publications stressed the need for a multidisciplinary panel, consumer
involvement, identification of clinical questions, systematic searches for
evidence, consultation beyond the development group, and regular reviews and
updates.
-
Distinguishing Association from Causation: A Backgrounder for Journalists
(Kathleen Meister). Description:
This 24 page report, published on October 29, 2007, by the American Council
on Science and Health, argues that randomized trials, if they can be
conducted, provide strong evidence for a causal effect. In contrast, animal
and in vitro experiments do not provide strong evidence for a causal
relationship but rather are useful for establishing biological mechanisms.
Observational studies can sometimes establish a causal relationship. The key
things to look for are temporality of the relationship, strength of the
relationship, a dose-response relationship, consistency across varied
conditions, and biological plausibility. This website was last verified on
2007-11-16. URL:
www.acsh.org/publications/pubID.1629/pub_detail.asp
- Kristin L. Carman, Maureen Maurer, Jill Mathews Yegian, et al. Evidence
That Consumers Are Skeptical About Evidence-Based Health Care. Health Aff.
2010;29(7):1400-1406. Abstract: "We undertook focus groups, interviews, and
an online survey with health care consumers as part of a recent project to
assist purchasers in communicating more effectively about health care evidence
and quality. Most of the consumers were ages 18-64; had health insurance
through a current employer; and had taken part in making decisions about
health insurance coverage for themselves, their spouse, or someone else. We
found many of these consumers' beliefs, values, and knowledge to be at odds
with what policy makers prescribe as evidence-based health care. Few consumers
understood terms such as "medical evidence" or "quality guidelines." Most
believed that more care meant higher-quality, better care. The gaps in
knowledge and misconceptions point to serious challenges in engaging consumers
in evidence-based decision making." [Accessed July 8, 2010]. Available at:
http://content.healthaffairs.org/cgi/content/abstract/29/7/1400.
- Helping Doctors and Patients Make Sense of Health
Statistics. Gerd Gigerenzer Wolfgang Gaissmaier Elke Kurz-Milcke Lisa M.
Schwartz Steven Woloshin. Psychological Science in the Public Interest 2008:
8(2); 53-96.
[Abstract]
[PDF]. Excerpt: Many doctors, patients, journalists, and politicians
alike do not understand what health statistics mean or draw wrong conclusions
without noticing. Collective statistical illiteracy refers to the widespread
inability to understand the meaning of numbers. For instance, many citizens
are unaware that higher survival rates with cancer screening do not imply
longer life, or that the statement that mammography screening reduces the risk
of dying from breast cancer by 25% in fact means that 1 less woman out of
1,000 will die of the disease. We provide evidence that statistical illiteracy
(a) is common to patients, journalists, and physicians; (b) is created by
nontransparent framing of information that is sometimes an unintentional
result of lack of understanding but can also be a result of intentional
efforts to manipulate or persuade people; and (c) can have serious
consequences for health.
- Clinical Evidence. How much do we know? Excerpt: "So what can
Clinical Evidence tell us about the state of our current knowledge? What
proportion of commonly used treatments are supported by good evidence, what
proportion should not be used or used only with caution, and how big are the
gaps in our knowledge? Of around 2500 treatments covered 13% are rated as
beneficial, 23% likely to be beneficial, 8% as trade off between benefits and
harms, 6% unlikely to be beneficial, 4% likely to be ineffective or harmful,
and 46%, the largest proportion, as unknown effectiveness (see figure 1)."
[Accessed February 4, 2010]. Available at:
http://clinicalevidence.bmj.com/ceweb/about/knowledge.jsp.
- Edzard Ernst. How Much of CAM is Based on Research Evidence? eCAM.
2009:nep044. Abstract: "The aim of this article is to provide a preliminary
estimate of how much CAM is evidence-based. For this purpose, I calculated the
percentage of 685 treatment/condition pairings evaluated in the Desktop Guide
to Complementary and Alternative Medicine' which were supported by sound data.
The resulting figure was 7.4%. For a range of reasons, it might be a gross
over-estimate. Further investigations into this subject are required to arrive
at more representative figures." [Accessed February 4, 2010]. Available
at:
http://ecam.oxfordjournals.org/cgi/content/abstract/nep044v1.
- Interesting quote: "Evidence, which we have means to strengthen
for or against a proposition, is our proper means for attaining truth."
Florence Nightingale as quoted in
www.causeweb.org/cwis/SPT--FullRecord.php?ResourceId=1836.
- Trevor Sheldon. Managing uncertainty in healthcare. Report of a meeting
organised by NICE and AHRQ. 2008. Abstract: "There are certain
challenges that confront virtually all health systems, irrespective of the
means by which they are funded and administered. One such is the management of
uncertainty: specifically, knowing what to do when data on the effectiveness
or the cost-effectiveness of new medicines or procedures is incomplete or
inadequate, but decisions have nonetheless to be taken on whether to purchase
and supply them to patients. A similar issue arises when there is suspicion
that a procedure or medicine already in use may be relatively ineffective or
represent poor value for money." [Accessed January 15, 2009]. Available
at:
http://www.nice.org.uk/media/A1A/E6/NICEAHRQWorkshopReportFINAL.pdf.
- Dariusz Leszczynski, Zhengping Xu. Mobile phone radiation health risk
controversy: the reliability and sufficiency of science behind the safety
standards. Health Research Policy and Systems. 2010;8(1):2. Abstract:
"There is ongoing discussion whether the mobile phone radiation causes any
health effects. The International Commission on Non-Ionizing Radiation
Protection, the International Committee on Electromagnetic Safety and the
World Health Organization are assuring that there is no proven health risk and
that the present safety limits protect all mobile phone users. However, based
on the available scientific evidence, the situation is not as clear. The
majority of the evidence comes from in vitro laboratory studies and is of very
limited use for determining health risk. Animal toxicology studies are
inadequate because it is not possible to "overdose" microwave radiation, as it
is done with chemical agents, due to simultaneous induction of heating
side-effects. There is a lack of human volunteer studies that would, in
unbiased way, demonstrate whether human body responds at all to mobile phone
radiation. Finally, the epidemiological evidence is insufficient due to, among
others, selection and misclassification bias and the low sensitivity of this
approach in detection of health risk within the population. This indicates
that the presently available scientific evidence is insufficient to prove
reliability of the current safety standards. Therefore, we recommend to use
precaution when dealing with mobile phones and, whenever possible and
feasible, to limit body exposure to this radiation. Continuation of the
research on mobile phone radiation effects is needed in order to improve the
basis and the reliability of the safety standards." [Accessed February 1,
2010]. Available at:
http://www.health-policy-systems.com/content/8/1/2.
- Trisha Greenhalgh. Narrative based medicine: Narrative based medicine
in an evidence based world. BMJ. 1999;318(7179):323-325. Excerpt: "In a
widely quoted riposte to critics who accused them of naive empiricism, Sackett
and colleagues claimed that "the practice of evidence based medicine means
integrating individual clinical expertise with the best available external
clinical evidence .... By individual clinical expertise we mean the
proficiency and judgment that individual clinicians acquire through clinical
experience and clinical practice." Sackett and colleagues were anxious to
acknowledge that there is an art to medicine as well as an objective empirical
science but they did not attempt to define or categorise the elusive quality
of clinical competence. This article explores the dissonance between the
"science" of objective measurement and the "art" of clinical proficiency and
judgment, and attempts to integrate these different perspectives on clinical
method." [Accessed December 5, 2009]. Available at:
http://www.bmj.com/cgi/content/full/318/7179/323.
- Vera Kalitzkus, Peter F. Matthiessen. Narrative-Based Medicine:
Potential, Pitfalls, and Practice. The Permanente Journal. 13(1):80-86.
Excerpt: "Narratives have always been a vital part of medicine. Stories about
patients, the experience of caring for them, and their recovery from illness
have always been shared—among physicians as well as among patients and their
relatives. With the evolution of “modern” medicine, narratives were
increasingly neglected in favor of “facts and findings,” which were regarded
as more scientific and objective. Now, in recent years medical narrative is
changing—from the stories about patients and their illnesses, patient
narratives and the unfolding and interwoven story between health care
professionals and patients are both gaining momentum, leading to the creation
or defining of narrative-based medicine (NBM). The term was coined
deliberately to mark its distinction from evidence-based medicine (EBM); in
fact, NBM was propagated to counteract the shortcomings of EBM.1,2 But what is
NBM? Is it a specific therapeutic tool, a special form of physician-patient
communication, a qualitative research tool, or does it simply signify a
particular attitude towards patients and doctoring? It can be all of the above
with different forms or genres of narrative or practical approach called for
depending on the field of application. In this article we will give a
systematic overview of NBM: a short historic background; the various narrative
genres; and an analysis of how the genres can be effectively applied in
theory, research, and practice in the medical field, with a focus on
possibilities and limitations of a narrative approach. " [Accessed
December 5, 2009]. Available at:
http://xnet.kp.org/permanentejournal/winter09/narrativemedicine.html.
- Trevor Sheldon. Managing uncertainty in healthcare. Report of a
meeting organised by NICE and AHRQ. 2008. Available at: www.nice.org.uk/media/A1A/E6/NICEAHRQWorkshopReportFINAL.pdf
[Accessed January 15, 2009]. Excerpt: There are certain challenges that
confront virtually all health systems, irrespective of the means by which they
are funded and administered. One such is the management of uncertainty:
specifically, knowing what to do when data on the effectiveness or the
cost-effectiveness of new medicines or procedures is incomplete or inadequate,
but decisions have nonetheless to be taken on whether to purchase and supply
them to patients. A similar issue arises when there is suspicion that a
procedure or medicine already in use may be relatively ineffective or
represent poor value for money.
- Narrative evidence based medicine. Rita Charon,
Peter Wyer, The NEBM Working Group. Lancet 2008: 371; 296-297.
[Full text]
[PDF]. Description: This article discusses the need to
combine the data-based emphasis of evidence based medicine with patient
experiences, illness narratives, and other sources such as contemporary
novels.
- Thomas B Newman. The power of stories over statistics. BMJ.
2003;327(7429):1424-1427. Excerpt: "Neonatal jaundice and infant safety on
aeroplanes provide two lessons on the power of narrative, rather than
statistical evidence, in determining practice." [Accessed December 10,
2009]. Available at: http://www.bmj.com.
- Ward A. The role of causal criteria in causal inferences: Bradford
Hill's "aspects of association". Epidemiologic Perspectives & Innovations.
2009;6(1):2. Available at: http://www.epi-perspectives.com/content/6/1/2
[Accessed June 24, 2009]. Abstract: As noted by Wesley Salmon and many
others, causal concepts are ubiquitous in every branch of theoretical science,
in the practical disciplines and in everyday life. In the theoretical and
practical sciences especially, people often base claims about causal relations
on applications of statistical methods to data. However, the source and type
of data place important constraints on the choice of statistical methods as
well as on the warrant attributed to the causal claims based on the use of
such methods. For example, much of the data used by people interested in
making causal claims come from non-experimental, observational studies in
which random allocations to treatment and control groups are not present.
Thus, one of the most important problems in the social and health sciences
concerns making justified causal inferences using non-experimental,
observational data. In this paper, I examine one method of justifying such
inferences that is especially widespread in epidemiology and the health
sciences generally - the use of causal criteria. I argue that while the use of
causal criteria is not appropriate for either deductive or inductive
inferences, they do have an important role to play in inferences to the best
explanation. As such, causal criteria, exemplified by what Bradford Hill
referred to as "aspects of [statistical] associations", have an indispensible
part to play in the goal of making justified causal claims.
- Kuna Gupta, Jyotsna Gupta, Sukhdeep Singh. Surrogate Endpoints: How
Reliable Are They? 2010. Excerpt: "Surrogate endpoints offer three main
advantages to clinical studies: The study becomes simpler. Since surrogates
are usually measures of symptoms or laboratory biomarkers, they make it easier
to quantify comparisons. The study becomes shorter. It generally takes less
time to see the effect of an intervention on a surrogate than on the final
clinical outcome, especially if the surrogate marks an intermediate point in
the disease process. The study becomes less expensive. Since the study
duration is shorter, the cost decreases. Measurement of the surrogate may be
less costly than measurement of the true outcome. In addition, waiting for a
clinical outcome may involve more medical care for sicker patients."
[Accessed May 3, 2010]. Available at:
http://www.firstclinical.com/journal/2010/1005_Surrogate.pdf.
- Jeremy Genovese. The Ten Percent Solution. Anatomy of an Education Myth.
Excerpt: "For may years, versions of a claim that students remember “10% of
what they read, 20% of what they hear, 30% of what they see, 50% of what they
see and hear, and 90% of what they do” have been widely circulated among
educators. The source of this claim, however, is unknown and its validity is
questionable. It is an educational urban legend that suggests a willingness to
accept assertions about instructional strategies without empirical support."
[Accessed March 25, 2010]. Available at:
http://www.skeptic.com/eskeptic/10-03-24/#feature.
- Ann Evensen, Rob Sanson-Fisher, Catherine D'Este, Michael Fitzgerald.
Trends in publications regarding evidence practice gaps: A literature review.
Implementation Science. 2010;5(1):11. Abstract: "BACKGROUND: Well-designed
trials of strategies to improve adherence to clinical practice guidelines are
needed to close persistent evidence-practice gaps. We studied how the number
of these trials is changing with time, and to what extent physicians are
participating in such trials. METHODS: This is a literature-based study of
trends in evidence-practice gap publications over 10 years and participation
of clinicians in intervention trials to narrow evidence-practice gaps. We
chose nine evidence-based guidelines and identified relevant publications in
the PubMed database from January 1998 to December 2007. We coded these
publications by study type (intervention versus non-intervention studies). We
further subdivided intervention studies into those for clinicians and those
for patients. Data were analyzed to determine if observed trends were
statistically significant. RESULTS: We identified 1,151 publications that
discussed evidence-practice gaps in nine topic areas. There were 169
intervention studies that were designed to improve adherence to
well-established clinical guidelines, averaging 1.9 studies per year per topic
area. Twenty-eight publications (34%; 95% CI: 24% - 45%) reported
interventions intended for clinicians or health systems that met Effective
Practice and Organization of Care (EPOC) criteria for adequate design. The
median consent rate of physicians asked to participate in these well-designed
studies was 60% (95% CI, 25% to 69%). CONCLUSIONS: We evaluated research
publications for nine evidence-practice gaps, and identified small numbers of
well-designed intervention trials and low rates of physician participation in
these trials." [Accessed February 4, 2010]. Available at:
http://www.implementationscience.com/content/5/1/11.
- Statistics as Principled Argument.
Abelson, R. P. (1995) Hillsdale, New Jersey: Lawrence Erlbaum Associates.
ISBN: 0805805281.
[BookFinder4U link]. Description: There is a wealth of wisdom in this
book. The theme of this book is that Statistics provides basic principles to
argue (debate might be a nicer word) about scientific claims. In the first
chapter, Dr. Abelson argues that a persuasive argument has to have
MAGIC--Magnitude, Articulation, Generality, Interestingness, and Credibility.
Then he describes probability and randomness, illustrates common fallacies
about probability, and shows how these principles can be applied to research
findings. Chapter 5, On Suspecting Fishiness, describes some wonderful
examples of strange numbers that might indicate fraud. This chapter is
especially valuable because it is so rarely covered. The remaining chapters
describe the MAGIC components of a persuasive argument with frequent citations
of real research. This book is more conceptual than computational, which fits
in with one of Abelson's Laws "Don't talk Greek if you don't know the English
translation."
- Survey of claims of no effect in abstracts of
Cochrane reviews. Phil Alderson, Iain Chalmers. BMJ 2003: 326(7387); 475.
[Medline]
[Full text]
[PDF]. Description: This article notes that claims about
"negative" results need to be phrased cautiously. In a review of 989 Cochrane
reviews, the authors found 240 poorly worded interpretations of no difference
or no effect.
-
The Taxonomy of Logical
Fallacies (Gary N. Curtis). Description:
Understanding flaws in the process of of advocating a particular viewpoint is
an important component of critical thinking. You can understand these flaws
better if you can ascribe them to a particular category. This website was
last verified on 2007-07-23. URL: www.fallacyfiles.org/taxonomy.html
-
Unconventional cancer therapies: What we need is rigorous research, not
closed minds. E. Ernst. Chest 2000: 117(2); 307-8.
[Medline]
[Full text]
[PDF]. Description: This article notes the popularity of
many complementary and alternative medicine techniques, but also warns of the
lack of methodological rigor in many evaluations of these techniques. Rather
than reject wholesale all of these techniques, these authors suggest that
rigorous research is needed.
-
William A Silverman. Where's the evidence? Controversies in modern medicine.
New York: Oxford University Press Excerpt: "Medicine is moving away from
reliance on the proclamations of authorities to the use of numerical methods
to estimate the size of effects of its interventions. But a rumbling note of
uneasiness underlines present-day medical progress: the more we know, The more
questions we encounter about what to do with the hard-won information. The
essays in Where's the Evidence examine the dilemmas that have arisen as the
result of medicine's unprecedented increase in technical powers. How do
doctors draw the line between "knowing" (the acquisition of new medical
information) and doing" (the application of that new knowledge)? What are the
long-term consequences of responding to the demand that physicians always do
everything that can be done? Is medicine's primary aim to increase the length
of life? Or is it to reduce the amount of pain and suffering? And who is
empowered to choose when these ends are mutually exclusive? This engaging
collection of essays will be of interest to professionals interested in the
evidence-based medicine debate, including epidemiologists, neonatologists,
those involved in clinical trials and health policy, medical ethicists,
medical students, and trainees."
-
William A Silverman. Where's the evidence? Controversies in modern medicine.
New York: Oxford University Press Excerpt: "Medicine is moving away from
reliance on the proclamations of authorities to the use of numerical methods
to estimate the size of effects of its interventions. But a rumbling note of
uneasiness underlines present-day medical progress: the more we know, The more
questions we encounter about what to do with the hard-won information. The
essays in Where's the Evidence examine the dilemmas that have arisen as the
result of medicine's unprecedented increase in technical powers. How do
doctors draw the line between "knowing" (the acquisition of new medical
information) and doing" (the application of that new knowledge)? What are the
long-term consequences of responding to the demand that physicians always do
everything that can be done? Is medicine's primary aim to increase the length
of life? Or is it to reduce the amount of pain and suffering? And who is
empowered to choose when these ends are mutually exclusive? This engaging
collection of essays will be of interest to professionals interested in the
evidence-based medicine debate, including epidemiologists, neonatologists,
those involved in clinical trials and health policy, medical ethicists,
medical students, and trainees. " Available at:
http://lccn.loc.gov/97052058.
-
Training of patient and consumer representatives in the basic competencies of
evidence-based medicine: a feasibility study. Berger B, Steckelberg A, Meyer
G, Kasper J, Mühlhauser I. BMC Med Educ. 2010 Feb 11;10:16.
-
Development and implementation of a science training course for breast cancer
activists: Project LEAD (leadership, education and advocacy development).
Dickersin K, et al Health Expect. 2001 Dec;4(4):213-20
-
Evidence-based consumer health information: developing teaching in critical
appraisal skills. Milne R, Oliver S International Journal for Quality in
Health Care, October 1996, vol./is. 8/5(439-45), 1353-4505;1353-4505 (1996
Oct)
All of the material above this paragraph is licensed under a
Creative Commons Attribution 3.0 United States License. This page was written by
Steve Simon and was last modified on
2010-08-19. The material
below this paragraph links to my
old website, StATS. Although I wrote all of the material
listed below, my ex-employer, Children's Mercy Hospital, has claimed copyright
ownership of this material. The brief excerpts shown here are included under
the fair use provisions of U.S. Copyright laws.
2008
- Stats: The post-modern assault
on evidence-based medicine, part 3 (January 7, 2008). I have volunteered
to give a talk for a group of statisticians which discusses an article I am
preparing: "The post-modern assault on evidence-based medicine." I might give
this talk on the first Monday in February or the first Monday in March. Here
is a tentative abstract.
2007
- Stats: The post-modern assault
on evidence-based medicine, part 2 (December 18, 2007). As mentioned in a
December 7, 2007 weblog entry, I sent an email to Michael Shermer, editor of
Skeptic Magazine. In it, I included a brief pitch for an article, "The
post-modern assault on evidence-based medicine" and he gave me some
encouragement to work on this. Guidelines for contributions are at http://www.skeptic.com/the_magazine/contribute.html
and they accept articles of varying lengths (500 to 5000 words) though they
prefer shorter articles. the current draft is already 2700 words with a lot
left to be written. So I'll have to find a way to condense many of these
thoughts. Here are some of the talking points in the article. I'm including
heading in this draft, but they are just to help me organize my thoughts.
This draft still needs a lot of work, but I wanted to have something to show
to people.
- Stats: The post-modern assault on
evidence-based medicine (December 7, 2007). I sent a brief email to
Michael Shermer, editor of Skeptic Magazine. In it, I included a brief pitch
for an article. The title would be "The post-modern assault on evidence-based
medicine."
- Stats: Which expert should you believe?
(August 3, 2007). There's a common saying in research circles that goes
something like this: "For every PhD, there is an equal and opposite PhD."
That saying is certainly true in my experience. For just about any scientific
controversy, you can find an expert on either side of the issue. Quite often
the experts on both sides know far more about the controversy than you or I
will ever get a chance to know. So the question becomes: "Which expert should
you believe?"
- Stats: The research world is not
black and white (July 7, 2007). I was asked to review a commentary about
studies involving remote healing (which includes prayer studies as a
subgroup). It is not available yet on the web, but I'll try to link to it
when it becomes available. One of the documents that this commentary did
refer to, however, is available on the web. Mistakes in Experimental
Design and Interpretation. Peter Norvig, norvig.com/experiment-design.html.
This is a good commentary, but it falls into a philosophical trap that
plagues most of the discussion on how to critically evaluate research,
including (I have to admit) some of my own commentaries.
- Stats: The Seven Deadly Sins of Researchers
(April 4, 2007). I was reading an article in written by Steven Goodwin,
The Seven Sins of Programmers, published in issue 17 of the Free Software
Magazine and thought it would be fun to use a similar theme in research. So
here are the seven deadly sins of researchers. Lest I be accused of the sin
of pride, let me admit that everyone, including myself has been tempted by
and has indulged in some of these sins at one point in their research career.
- Stats: Ignore weak evidence at your own
peril (March 13, 2007). I ran across an interesting article recently:
Incorporating quality of evidence into decision analytic modeling. R. S.
Braithwaite, M. S. Roberts, A. C. Justice. Ann Intern Med 2007: 146(2);
133-41. I have not yet read the full article, but the message seems to be
that using evidence from weak data sources is better than ignoring it.
2006
- Stats: Ambiguous nature of the word
"risk" (September 13, 2006). A recent discussion on the Evidence-Based
Health email discussion group focused on the word "risk". It means harmful
event (risks versus benefits) as well as a probability (risk of heart
attack).
- Stats: Why do we need research? (May 31,
2006). I help a lot of people to perform research and it's important to
understand why research is important. We do research because good research
drives out bad medical practices.
- Stats: No tolerance for ambiguity
(May 10, 2006). I was at a meeting tonight and put in a plug for my book,
Statistical Evidence in Medical Trials, by mentioning that it was intended to
help people understand the controversies and the seemingly contradictory
research that appears in the medical journals. A woman talked to me
afterwards and wanted to know what I thought about a particular author who
had written about hormone replacement therapy. I had to defer any comments
because I was unfamiliar with this particular author. She then informed me
that she had taken hormone replacement therapy and it gave her breast cancer.
Thankfully, the cancer has responded well to treatment, but I was struck by
the certainty of her comment about how the estrogen supplements caused her
cancer.
- Stats: Contradictory research
(March 30, 2006). The Washington Post published an article that gets to
the heart of the difficulty with Evidence Based Medicine, Fat or
Fiction? Is There a Link Between Dietary Fat and Cancer Risk? Why Two Big
Studies Reached Different Conclusions. Lisa M. Schwartz, Steven
Woloshin, H. Gilbert Welch, Published March 14, 2006 in The Washington Post,
Page HE01. It starts out with a rather provocative statement, but one that is
very hard to argue with, "The public is bombarded with messages about diet
and cancer prevention. Unfortunately, the advice is pretty inconsistent. One
day a diet prevents cancer, the next day it doesn't. In the early '90s, beta
carotene (a vitamin A precursor present in fruits and vegetables) was said to
prevent lung cancer. But several years later, headlines read, "Beta carotene
pills yield no benefit" (The Post, 1996). And while people have been told for
years to eat a high-fiber diet to reduce the risk of colon cancer, recently
we were told "High-fiber diets are not anti-cancer miracle" (Montreal
Gazette, 2005)."
- P.Mean: Integrating internal and
external evidence (created 2006-03-17). This article was originally
published on my old website, but it seems to have disappeared. I'm reproducing
it here with a few revisions. Evidence based medicine involves the combining
of the best available evidence with your clinical knowledge and the patient's
individual values. A good article that emphasizes how this should be done is
on the web at: Evidence-based decision making--the six step approach. Franz
Porzsolt, Andrea Ohletz, Anke Thim, David Gardner, Helmuth Ruatti, Horand
Meier, Nicole Schlotz-Gorton, Laura Schrott. Evid Based Med 2003: 8(6);
165-166.
- Stats: More on the Emily Rosa
experiment (March 10, 2006). One of the more interesting research studies
from an Evidence-Based Medicine perspective started out as a simple science
fair project by a fourth grade student. Emily Rosa wanted to see if
practitioners of Therapeutic Touch could detect the energy fields in a
carefully controlled condition. The topic of this project was not too
surprising, since her parents both worked for the QuackWatch website, but
Emily came up with the idea entirely on her own. The science project received
a lot of publicity and Emily was encouraged to publish here results in a
medical journal. With the assistance of several adults, the publication, A
close look at therapeutic touch. L. Rosa, E. Rosa, L. Sarner, S. Barrett.
Jama 1998: 279(13); 1005-10, appeared, giving Emily Rosa something nice to
put on her resume when she applies to college. I'm still waiting for my first
publication in an "A journal" like JAMA, so I am quite jealous.
2005
- Stats: A nice definition of anecdotal
evidence (October 24, 2005). Robert Todd Carroll, author of The Skeptics
Dictionary and creator of the website Skepdic.com, mentioned in a recent
newsletter that he has updated his definition for anecdotal evidence. He
points out that anecdotes are unreliable because they are "prone to
contamination by beliefs, later experiences, feedback, selective attention to
details, and so on." and although these are "scientifically worthless",
their vivid details make them popular. But Dr. Carroll wisely does not
totally rule out their use.
- Stats: What is critical thinking? (May
17, 2005). A lot of people use the term "critical thinking" in an offhand
way. Usually the writer who uses this term is trying to imply that anyone who
disagrees with the writer's theory or belief is naive. Critical thinking is
also produced as an excuse to attack a particular theory or to promote "equal
time" for a competing belief. Critical thinking, however, is much more
complex than this. It involves more than just fault finding.
- Stats: Effective communication about
randomized clinical trials (February 22, 2005). The most recent issue of
BMJ has a nice article evaluating a training program for health care
professionals. This is an unusual thing to do; most of the time, training
programs are just put together with the assumption that because intelligent
people are designing the program, it must be effective. I'm just as guilty of
this as anyone else, of course. The particular training class is of great
interest to me, because it works on how health care professionals communicate
to patients about randomized clinical trials.
- Stats: How good is your intuition? (January
21, 2005). One definition of Evidence Based Medicine is "the
conscientious, explicit, and judicious use of current best evidence in making
decisions about the care of individual patients. The practice of evidence
based medicine means integrating individual clinical expertise with the best
available external clinical evidence from systematic research. Sackett et
al 1996." In the same article, the authors point out that "Good doctors
use both individual clinical expertise and the best available external
evidence, and neither alone is enough. Without clinical expertise, practice
risks becoming tyrannised by evidence, for even excellent external evidence
may be inapplicable to or inappropriate for an individual patient. Without
current best evidence, practice risks becoming rapidly out of date, to the
detriment of patients." A recently published book by Malcolm Gladwell
highlights the value of individual expertise, which you might also call
clinical judgment or simply intuition.
2004
- Stats: Entrenched beliefs (December
1, 2004). A member of the Evidence Based Health listserv wrote about a
workshop he taught on Evidence Based Medicine (EBM). It went pretty well, he
thought until he overheard a conversation during one of the breaks. A doctor
was recommending an herbal remedy to a friend with the comment: "It cleared
my problem up really quickly." This demonstrated to him how readily we still
accept anecdotal evidence instead of EBM. I think it is just a fundamental
characteristic of human nature to apply critical thinking skills to
everything except a core set of beliefs that you hold near and dear to your
heart.
- Stats: Anecdotal information
(November 2, 2004). Anecdotal information is problematic for several
reasons, and I have highlighted some of these reasons in a speech I gave at
the 2004 meeting of the Midwest Society for Pediatric Research.
Catherine Fiorello highlights the weakness of the anecdotal argument "I
was spanked as a child and I turned out okay." Such an observation
ignores the need for a comparison group. Such a group would help answer the
question "What would I have been like if I hadn't been spanked as a child?"
- Stats: Craniosacral therapy (September 24,
2004). An educational email circulated at our hospital during Pain
Awareness Week has two interesting questions that draw a sharp contrast
between traditional medicine and alternative medicine.
- Stats: Statistical nihilism (July 6, 2004).
There's an enormous mistrust of statistics in the real world. To the extent
that it makes people skeptical, that's good. To the extent it turns them
cynical, that's bad. There's a viewpoint, championed by too many people, that
statistics are worthless. I call this viewpoint statistical nihilism.
- Stats: Overlooking one's own flaws (May 3, 2004).
Can we ever be truly objective about ourselves? Maybe not. A recent article
in Scientific American by Michael Shermer, The Enchanted Glass, talks
about the tendency to see ourselves more positively than our peers. For
example, when asked the probability that certain people will go to heaven,
the surveyors listed Bill Clinton at 52%, Mother Theresa at 79% and so forth.
But these same people rated their own probability at 87%.
2000
- Stats: Flaws in a research paper (January 27,
2000). Dear Professor Mean: A small group I've been teaching has
gotten extremely interested in how to decide when there are too many flaws in
a paper which would completely invalidate (and circular file) it.
- Stats: Jargon in Statistics (January 27, 2000).
Dear Professor Mean: I have to review a paper for journal club and I don't
understand all the obscure statistical jargon that the authors use.
Closely related categories:
What now?
Browse other categories at this site
Browse through the most recent entries
Get help
This work is licensed under a
Creative Commons Attribution 3.0 United States License. This page was written by
Steve Simon and was last modified on
2010-08-19.